Methods
The study group consisted of 65 biopsy proven temporal arteritis patients (20 males and 45 females). Twelve patients (two males and 10 females) fulfilling diagnostic criteria for polymyalgia rheumatica were also included for comparison purposes. All of the later had a negative temporal artery biopsy and never presented cranial manifestations suggestive of temporal arteritis during the period of disease activity or during a three year follow up period.
Data concerning clinical manifestations were obtained prospectively in patients with active disease and in those in recent remission. In individuals in long term remission, clinical information was obtained from their records and completed with an interview with every patient and a general physical examination.
A cross sectional study was performed and patients were classified according to their disease activity. Temporal arteritis or polymyalgia rheumatica were considered active when patients were clinically symptomatic and evaluated previously or within the first week after starting treatment (prednisone 1 mg kg-' d-' for temporal arteritis and 15 mg d-' for polymyalgia rheumatica). They were considered to be in recent remission when complete recovery of their symptoms occurred, with normalisation of erythrocyte sedimentation rate (ESR), after treatment for at least one month. Patients were considered to be in long term remission when they had been asymptomatic for three or more years after the beginning of treatment. At the time when vWFAg was determined four of the latter had slightly raised or borderline ESR values which did not result in a clinical flare or require changes in their treatment schedule.
The control group included 16 healthy blood donors (nine males, seven females) aged 63 years (range 60-65). The smoking habits of patients, controls, and pooled plasma donors were not recorded.
Measurements ofvWFAg were performed as described.9 A pool of plasma samples from normal donors was used as a reference and vWF activity present in this plasma pool was arbitrarily considered to contain 100 U dl-of VWFAg activity.
For the cross sectional study, 96 determinations were made: 36 in active temporal arteritis patients, 24 in temporal arteritis patients in recent remission (mean seven months, range one to 20 months), 18 in long term remission patients (mean six years, range three to 13 years), 12 in patients with active isolated polymyalgia rheumatica, and six in patients with temporal arteritis and associated diseases: one acute myocardial infarction, four infections (one pneumonia, one acute pyelonephritis with sepsis, one miliary tuberculosis, one oropharyngeal candidiasis), and one dehydration and renal insufficiency secondary to hypercalcaemia caused by coincident primary hyperparathyroidism. In addition, 14 
) were also significantly higher than those from normal donors (P < 0.05). Although vWFAg concentrations tended to be higher in temporal arteritis than in polymyalgia rheumatica the difference was not statistically significant (fig 1) .
Among patients with active temporal arteritis 
